HOME >> MEDICINE >> NEWS
Hormone drug linked to increased prevalence of male genital disorder

Results of a Dutch study in this weeks issue of THE LANCET highlight how a male genital disorder could be more common among boys born to mothers who were prenatally exposed to a synthetic hormone withdrawn in the late 1970s.

The drug diethylstilbestrol (DES) was previously prescribed to prevent spontaneous abortion and preterm delivery. DES was withdrawn in the 1970s when it became clear that it was associated with vaginal cancer and fertility disorders in women who were exposed to the drug prenatally. Flora Van Leeuwen and colleagues from The Netherlands Cancer Institute, Amsterdam, Netherlands, aimed to establish the risk of hypospadias (a birth defect in boys where the urethral opening occurs on the underside of the penis or the scrotum) in sons of women who were prenatally exposed to DES.

The investigators did a population study of around 8900 sons of over 16,000 women with fertility problems in The Netherlands. Mothers of 205 boys reported prenatal DES exposure. Four of these children were reported to have hypospadias. In the remaining 8729 children, only eight cases of hypospadias were reported, indicating that hypospadias was more than 20 times as common in boys whose mothers were exposed to DES.

In an accompanying Commentary (p 1081), Sonia Hernndez-Daz from Boston University School of Public Health, USA, concludes: "Although diethylstilbestrol is no longer used, research on exposure to this drug may be relevant to current concerns about exposures to weaker oestrogens such as synthetic hormones present in oral contraceptives, phyto-oestrogens in the diet, or certain pesticides or solvents. Knowledge gained from the diethylstilbestrol debacle should be used to guide research on the possible risks associated with oestrogens that are being encountered by current generations."


'"/>

Contact: Richard Lane
richard.lane@lancet.com
44- 20-7424-4949
Lancet
28-Mar-2002


Page: 1

Related medicine news :

1. Hormone therapy increases risk of urinary incontinence
2. Hormone therapy controversy raises drug safety issues
3. Endocrine Society and Hormone Foundation call for increased research
4. Hormone therapy may still offer important health benefits to postmenopausal women
5. Hormone may offer hope for treating some behavioral disorders
6. Hormone found to protect bones
7. Hormone released by bone marrow cells may hasten recovery from brain injury
8. Hormones increase side effects, complicate treatment decision for prostate cancer patients
9. Hormones and drugs that control blood pressure also control malaria infection
10. Hormone replacement therapy reviewing the evidence
11. Hormone prompts adult stem cells to differentiate into islet cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
Breaking Medicine Technology:
Cached News: